Conditions: CHRONIC SPONTANEOUS URTICARIA
Keywords: CHRONIC SPONTANEOUS URTICARIA OMALIZUMAB URTICARIA CONTROL TEST IGE025
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 136
Healthy volunteers: no

Brief summary:
Evaluate the proportion of patients with an urticaria control test \[UCT\] score of greater than or equal to 12 at Week 12.

Detailed description:

Arms:
arm 1: sub cutaneous injections of 300 mg every 4 weeks until Week 8.

Interventions: intervention 1: OMALIZUMAB
Intervention descriptions: intervention 1: sub cutaneous injections of 300 mg every 4 weeks until Week 8.

Protocol document: